Technological advancements in radiotherapy and the rising incidence of cancer are the major factors driving the growth of radiotherapy market. Additionally, the growing adoption of radiotherapy procedures for cancer treatment, increasing use of particle therapy for cancer treatment, and the rising number of conferences and symposia focusing on the advancements in radiotherapy are some of the other major factors driving the growth of this market.
The global radiotherapy market is projected to reach USD 6.8 billion by 2023 from USD 5.6 billion in 2018, at a CAGR of 4.1%
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=567
Radiotherapy Market Insights by Application:
Based on application, the external beam radiotherapy market is segmented into prostate cancer, breast cancer, lung cancer, head & neck cancer, colorectal cancer, and other cancers. The prostate cancer segment is expected to account for the second-largest share of the radiotherapy market in 2018. The growing incidence of prostate cancer and the high success rates and minimal long-term risks achieved with external beam radiotherapy are the major factors driving the growth of this market segment.
Radiotherapy Market Analysis by Type:
Based on type, the external beam radiotherapy market is classified into IGRT, IMRT, stereotactic therapy, particle beam therapy, and 3D-CRT. The IMRT segment is further classified into VMAT and TomoTherapy. The particle beam therapy segment is expected to witness the highest CAGR during the forecast period. Advancements in the field of particle beam therapy (such as PBS) and increasing research activities in the field of radiation oncology using proton therapy systems are the key factors driving the growth of this segment.
Key Players In Global Radiotherapy Devices Market:
The major players operating in the radiotherapy market are Varian Medical Systems, Inc. (US), Elekta (Sweden), Accuray Incorporated (US), Ion Beam Applications SA (Belgium), ViewRay, Inc. (US), IsoRay Medical, Inc. (US), Hitachi Ltd. (Japan), Panacea Medical Technologies Pvt. Ltd. (India), Provision Healthcare (US), Mevion Medical Systems, Inc. (US), Sumitomo Heavy Industries, Ltd. (Japan), Optivus Proton Therapy, Inc. (US), P-cure Ltd. (Israel), Theragenics Corporation (US), and C.R.Bard, Inc. (US).
Regional Growth Analysis Of Radiotherapy Market:
The radiotherapy market is segmented into four regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World. The North American region is expected to account for the largest share of the radiotherapy market in 2018.
Recent Developments In Global Radiotherapy Market:
In 2017, Mitsubishi Electric signed an agreement to transfer its particle therapy systems business to Hitachi and integrate into one entity.
In 2017, Varian Medical Systems opened its new facility in Jundiai, Brazil. This expansion is aimed to increase access to advanced radiotherapy treatment in the country.
In 2016, Varian Medical Systems launched an innovative treatment platform-Halcyon Treatment System. The product simplifies treatment delivery with high-quality plans delivered at significantly increased speeds.
Radiotherapy : Comprehensive Insights and Growth Potential In The Future
The global teleradiology market size is estimated to reach USD 11.5 billion by 2026 registering a CAGR of 18.4%, according to a new report by Grand View Research, Inc.
Rising prevalence of chronic diseases, such as osteoporosis and arthritis, along with growing geriatric population are expected to drive the market.
According to the WHO, 9.6% of men and 18% of women are suffering from various forms of arthritis, globally.
Over 82% of people suffering from osteoarthritis have difficulty in movement and around 25% are not able to perform daily activities.In addition, legislative amendments made by various governments worldwide for diagnostic imaging services will enhance the growth of this market during the forecast period.
This has allowed better access to diagnostic imaging for various conditions.
North America was the major regional market in 2018 and accounted for 39.45% of the global share due to factors, such as higher amount of funding for R, patient awareness levels, and cancer prevalence.The region is likely to expand further on account of favorable government initiatives for improving the healthcare facilities in rural areas and increased healthcare expenditure in this region are contributing to the market growth.
The global image-guided therapy systems market size was valued at USD 2.2 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 6.0% from 2021 to 2028.
The rise in the geriatric population and shifting preference for minimally invasive surgeries, along with technological advancements in imaging systems, are the key factors driving the market.According to the United Nations-World Population Prospects, 2019, about 16% of the global population or one in six people will be aged above 65 by 2050, up from 9% in 2019.
According to the WHO, the global cause of death is shifting from infections to chronic conditions, including high cholesterol, hypertension, cancer, and cognitive heart diseases.
Thus, the demand for image-guided therapy systems for treating these conditions is expected to rise in the coming years.For Right Perspective & Competitive Insights, Request a Sample @: https://www.grandviewresearch.com/industry-analysis/image-guided-therapy-systems-market/request/rs1 Key Player Mentioned:Koninklijke Philips N.V.MedtronicSiemens HealthineersAnalogic CorporationGE HealthcareVarian Medical Systems, Inc.According to the Institute of Cancer Research, more than 120,000 people in the U.K. are treated with radiotherapy annually.
Image-guided therapy systems have significantly improved, resulting in more precise and safer interventions.
Product Segment Analysis: Ultrasound SystemsComputed Tomography (CT) ScannersPositron Emission Tomography (PET)EndoscopesMagnetic Resonance Imaging (MRI)Application Segment Analysis:Cardiac SurgeryNeurosurgeryOrthopedic SurgeryUrologyOncology SurgeryRegional Segment Analysis: North America, Europe, Asia Pacific, Latin America, and Mideast and Africa.Segment is also projected to expand at the fastest CAGR during the forecast period owing to technological advancements in endoscopy and subsequent product launches.
According to the new market research report by MarketsandMarkets, [128 Pages Report] the global vascular closure devices market is expected to reach USD 984.6 Million by 2022 from USD 704.8 Million in 2017, at a CAGR of 6.9%.The large number of approvals for vascular closure devices, the high prevalence of cardiovascular diseases, high prevalance of obesity, and increasing focus of market players on large-bore vascular closure devices.The report provides an overall understanding of the market.
The geographic segments included in this report are North America, Europe, Asia-Pacific, and the Rest of the World (RoW).Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=180101468The Passive Approximators segment to grow at the highest CAGR during the forecast periodOn the basis of type, the global vascular closure device market is segmented into passive approximators, active approximators, and external hemostatic devices.
The passive approximators consist of a plug, sealant, or a gel that can be deployed at the arteriotomy site to passively close the femoral artery.
The key factors propelling the growth of the the vascular closure devices market are the rising prevalence of cardiovascular diseases, increase in obese population, increasing number of regulatory approvals, and increasing focus of market players on large-bore vascular closure devices.The increasing interventional procedures using radial access, the high cost of vascular closure devices, and the risks associated with vascular closure devices are the major restraints for the marketVascular closure devices are relatively high-priced devices compared to manual compression devices.
The cost of VCDs essentially adds up to the patient’s hospitalization bill and even increases the per patient cost for hospitals and simultaneously reduces profits.Moreover, radial artery access makes it more convenient for doctors to achieve hemostasis using simple manual compression methods.
Interventional procedures using radial artery access do not generally require vascular closure devices, which is another factor that leads to cost savings.Additionally, malfunctioning of devices, poor quality, and underperformance of devices are the primary causes of product recalls.
The global teleradiology market size is estimated to reach USD 11.5 billion by 2026 registering a CAGR of 18.4%, according to a new report by Grand View Research, Inc.
Rising prevalence of chronic diseases, such as osteoporosis and arthritis, along with growing geriatric population are expected to drive the market.
According to the WHO, 9.6% of men and 18% of women are suffering from various forms of arthritis, globally.
Over 82% of people suffering from osteoarthritis have difficulty in movement and around 25% are not able to perform daily activities.In addition, legislative amendments made by various governments worldwide for diagnostic imaging services will enhance the growth of this market during the forecast period.
This has allowed better access to diagnostic imaging for various conditions.
North America was the major regional market in 2018 and accounted for 39.45% of the global share due to factors, such as higher amount of funding for R, patient awareness levels, and cancer prevalence.The region is likely to expand further on account of favorable government initiatives for improving the healthcare facilities in rural areas and increased healthcare expenditure in this region are contributing to the market growth.
The global image-guided therapy systems market size was valued at USD 2.2 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 6.0% from 2021 to 2028.
The rise in the geriatric population and shifting preference for minimally invasive surgeries, along with technological advancements in imaging systems, are the key factors driving the market.According to the United Nations-World Population Prospects, 2019, about 16% of the global population or one in six people will be aged above 65 by 2050, up from 9% in 2019.
According to the WHO, the global cause of death is shifting from infections to chronic conditions, including high cholesterol, hypertension, cancer, and cognitive heart diseases.
Thus, the demand for image-guided therapy systems for treating these conditions is expected to rise in the coming years.For Right Perspective & Competitive Insights, Request a Sample @: https://www.grandviewresearch.com/industry-analysis/image-guided-therapy-systems-market/request/rs1 Key Player Mentioned:Koninklijke Philips N.V.MedtronicSiemens HealthineersAnalogic CorporationGE HealthcareVarian Medical Systems, Inc.According to the Institute of Cancer Research, more than 120,000 people in the U.K. are treated with radiotherapy annually.
Image-guided therapy systems have significantly improved, resulting in more precise and safer interventions.
Product Segment Analysis: Ultrasound SystemsComputed Tomography (CT) ScannersPositron Emission Tomography (PET)EndoscopesMagnetic Resonance Imaging (MRI)Application Segment Analysis:Cardiac SurgeryNeurosurgeryOrthopedic SurgeryUrologyOncology SurgeryRegional Segment Analysis: North America, Europe, Asia Pacific, Latin America, and Mideast and Africa.Segment is also projected to expand at the fastest CAGR during the forecast period owing to technological advancements in endoscopy and subsequent product launches.
According to the new market research report by MarketsandMarkets, [128 Pages Report] the global vascular closure devices market is expected to reach USD 984.6 Million by 2022 from USD 704.8 Million in 2017, at a CAGR of 6.9%.The large number of approvals for vascular closure devices, the high prevalence of cardiovascular diseases, high prevalance of obesity, and increasing focus of market players on large-bore vascular closure devices.The report provides an overall understanding of the market.
The geographic segments included in this report are North America, Europe, Asia-Pacific, and the Rest of the World (RoW).Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=180101468The Passive Approximators segment to grow at the highest CAGR during the forecast periodOn the basis of type, the global vascular closure device market is segmented into passive approximators, active approximators, and external hemostatic devices.
The passive approximators consist of a plug, sealant, or a gel that can be deployed at the arteriotomy site to passively close the femoral artery.
The key factors propelling the growth of the the vascular closure devices market are the rising prevalence of cardiovascular diseases, increase in obese population, increasing number of regulatory approvals, and increasing focus of market players on large-bore vascular closure devices.The increasing interventional procedures using radial access, the high cost of vascular closure devices, and the risks associated with vascular closure devices are the major restraints for the marketVascular closure devices are relatively high-priced devices compared to manual compression devices.
The cost of VCDs essentially adds up to the patient’s hospitalization bill and even increases the per patient cost for hospitals and simultaneously reduces profits.Moreover, radial artery access makes it more convenient for doctors to achieve hemostasis using simple manual compression methods.
Interventional procedures using radial artery access do not generally require vascular closure devices, which is another factor that leads to cost savings.Additionally, malfunctioning of devices, poor quality, and underperformance of devices are the primary causes of product recalls.